Condition
Mifepristone
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
33.3%-53% vs avg
Key Insights
Highlights
Success Rate
33% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
50.0%
2 terminated out of 4 trials
Success Rate
33.3%
-53.2% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results33% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Early P 1 (1)
P 2 (1)
Trial Status
Terminated2
Unknown1
Completed1
Trial Success Rate
33.3%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04588688Phase 2Terminated
Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency
NCT05151016Early Phase 1Unknown
Long-term Use of Mifepristone in the Treatment of Adenomyosis
NCT03727308Completed
Study of Clinic-based Versus Self-use of Medical Abortion Pills
NCT01636063Not ApplicableTerminated
Mifepristone Versus Misoprostol for Cervical Preparation Prior to Surgical Abortion Between 11 to 15 Weeks
Showing all 4 trials